|
轉(zhuǎn)載自“美捷登”，文章版權(quán)歸武漢美捷登生物有限公司所有。
作者：美捷登 Kristen
文章投稿后因某些原因需要更改或增加署名，這種情況應(yīng)該如何謹(jǐn)慎處理呢？申請(qǐng)了之后，雜志社是會(huì)同意還是會(huì)不同意因此拒稿呢？下面就和大家分享這種情況三類通常的處理方式。 第一類雜志官網(wǎng)針對(duì)更改或增加署名的請(qǐng)求有明確說明需要作者如何處理，按稿約要求處理即可。如BMC系列雜志，官網(wǎng)里面明確寫明“Authors wishing to make changes to authorship will be asked to complete our change of authorship form. Please note that changes to authorship cannot be made after acceptance of a manuscript.”只要有合適的理由，且所有作者簽署完成Change of authorship form（作者署名變更表），BMC系列雜志在接受前是可以修改作者信息的。 案例一方醫(yī)生（化名）的文稿投稿BMC Musculoskeletal Disorders（ISSN: 1471-2474）被修回后，因?yàn)槟承┰蛞{(diào)整作者信息，刪減兩位作者，增加一位作者。因BMC系列雜志修改作者按稿約中要求處理即可，所以修回雜志社之前作者直接填寫了一份Change of authorship form，里面詳細(xì)寫明了作者變更原因，所有涉及到的作者也都有簽字同意。修回雜志社的時(shí)候?qū)⒃摵炞治募徊⑻峤唤o了雜志社，目前該篇文章已被該雜志接受。 BMC系列以外也有類似操作的雜志，如Journal of Cellular Biochemistry。 案例二李醫(yī)生（化名）的文稿投稿Journal of Cellular Biochemistry（ISSN: 0730-2312）被修回后，作者因?yàn)槟承┰蛐枰略鲆晃还餐蛔�，查看了雜志官網(wǎng)，關(guān)于Correction to authorship(修改作者信息)有詳細(xì)說明：In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Journal of Cellular Biochemistry will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. 因而作者按要求簽署完成了Request for Changes to a Journal Article Author List Form，說明了新增作者在修回階段所做的貢獻(xiàn)，系統(tǒng)提交后雜志社沒有提出疑問，目前該篇文章已被該雜志接受。
第二類雜志官網(wǎng)針對(duì)更改或增加署名沒有明確說明該如何處理，則修回雜志社的時(shí)候在Cover letter里說明清楚作者的變更及理由（如有新增作者說明該作者在修回階段對(duì)文稿所做貢獻(xiàn)），之后雜志社會(huì)來信告知具體需要如果處理，按照雜志社要求提供相關(guān)資料發(fā)回即可。 案例三王醫(yī)生（化名）的文稿投稿Journal of Clinical Laboratory Analysis (ISSN: 0887-8013)被修回后，作者因?yàn)槟承┰蛭恼碌诙髡咝枰獎(jiǎng)h掉。由于沒有在該雜志網(wǎng)站看到具體修改作者信息的操作，所以在修回雜志社的時(shí)候，作者在Cover letter中做了詳細(xì)說明，提交后收到雜志社的信件“Your manuscript has been unsubmitted for the following reasons: It seems that an author has been removed between revisions. Please could you contact us to clarify the reason(s) for the change in authorship. Please also ask all the authors to contact us individually and give their consent to the removal of an author.”，因此通訊作者回信解釋了刪除作者的原因，并請(qǐng)各位作者單獨(dú)給雜志社去信表示同意刪除該作者。之后雜志社又給作者發(fā)了一份Authorship-change-form要求所有作者簽署后通過系統(tǒng)提交，提交后該文章被該雜志接受了。 案例四張醫(yī)生（化名）的文稿投稿Journal of Bioenergetics and Biomembranes（ISSN: 0145-479X）修回后，作者因?yàn)槟承┰蛐枰略鲆晃坏谌髡�，由于沒有在該雜志網(wǎng)站看到具體修改作者信息的操作，所以在修回雜志社的時(shí)候，作者在Cover letter中做了詳細(xì)說明，提交后收到雜志社的信件“During the initial check we have noticed a discrepancy in the authors list between the previous version and this version. Could you please clarify this change, and also let us know if all co-authors are aware of this? Please fill in the attached form and upload it together with your revision. Please note that all contributing authors should sign the form.” 之后請(qǐng)所有作者按要求簽署完成Change of authorship request form，系統(tǒng)提交后雜志社沒有提出進(jìn)一步疑問，但很遺憾該文章因最終審稿意見不太樂觀被拒稿了。
第三類雜志官網(wǎng)針對(duì)更改或增加署名沒有明確說明該如何處理，則修回雜志社的時(shí)候在Cover letter里說明清楚作者的變更及理由，如有新增作者需說明該作者在修回階段對(duì)文稿所做貢獻(xiàn)。但是有的雜志社不接受更改作者，文章可能會(huì)被直接拒稿。針對(duì)這類雜志，如果想更改作者，作者就需要謹(jǐn)慎小心了。 案例五劉醫(yī)生（化名）的文稿投稿Annals of Medicine（ISSN: 0785-3890）被修回后，作者因?yàn)槟承┰蛐枰略鲆晃坏谌髡�，由于沒有在該雜志網(wǎng)站看到具體修改作者信息的操作，所以在修回雜志社的時(shí)候，作者在Cover letter中做了詳細(xì)說明，但很遺憾文章因此被拒稿了，雜志社意見“We received the second-round reviewer comments and read your rebuttal letter together with the revised manuscript. We noticed that you added a new co-author to your manuscript after the first round of peer review process. This lead us to in-house evaluation as well as consultation with the ICMJE recommendations to reconsider your submission. Therefore, as the outcome, I regret to inform you that we cannot consider your manuscript for publication in Annals of Medicine. Thank you for allowing us to review this work. I very much regret that the decision was a negative one.”該雜志并沒有給作者繼續(xù)解釋及填寫更改作者信息表的機(jī)會(huì)。 以上是和大家分享的幾類更改或增加署名常見處理方式及結(jié)局。大家可以看到，投稿后如果要更改或增加署名，雜志社一般不會(huì)直接同意，不同雜志對(duì)此的處理方式及態(tài)度不一，且一般文章接受后大多數(shù)雜志是不允許作者更改或增加署名的。因此也提醒大家最好能在投稿前確定好作者署名及順序，在投稿后盡量不要再做修改。國際醫(yī)學(xué)期刊編輯委員會(huì)（ICMJE）明確定義了Authorship Criteria（作者標(biāo)準(zhǔn)），即作為文章作者需要滿足的條件，SCI期刊也遵循此準(zhǔn)則。Authorship should be given upon meeting all 4 of the following criteria proposed (verbatim) by the International Committee of Medical Journal Editors (ICMJE): (1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND (2) Drafting the work or revising it critically for important intellectual content; AND (3) Final approval of the version to be published; AND (4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. 文章在署名的時(shí)候，作者需要確認(rèn)是否每位作者都同時(shí)滿足如上4點(diǎn)達(dá)到了作為作者的要求，若沒有則需要考慮將該作者放到Acknowledgments（致謝）部分。
以上就是對(duì)投稿后作者要更改或增加署名的一些經(jīng)驗(yàn)分享，希望能對(duì)大家有幫助，謝謝！
轉(zhuǎn)載本文請(qǐng)聯(lián)系原作者獲取授權(quán)，同時(shí)請(qǐng)注明本文來自美捷登。【美捷登原創(chuàng)】SCI投稿之投稿后作者要更改或增加署名怎么辦？ | 
樓主
收藏
分享
支持
反對(duì)
提升卡
置頂卡
沉默卡
喧囂卡
變色卡
千斤頂
照妖鏡